Divya Rao
Analyst, TD Callen (substituting for Mark)
Replay available
Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) Q1 2025 earnings conference call, held 2025-05-01. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Unknown Speaker
Unidentified (no details provided)
Hiro Nagayomi
Analyst, Cantor (on behalf of Eric Schmidt)
Alec Stranahan
Analyst, Bank of America
Gregory Renza
Analyst, RBC Capital Markets
Chris Taylor
Vice President of Investor Relations and Corporate Communications
Brian Goff
Chief Executive Officer
Emily Bodnar
Analyst, HC Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Agios Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.078 Good morning and welcome to AGO's first quarter 2025 conference call. 00:00:05.078 -- 00:00:07.981 At this time, all participants are on a listen-only mode. 00:00:07.981 -- 00:00:10.685 There will be a question-answer session at the end. 00:00:10.685 -- 00:00:14.370 Please be advised that this call is being recorded at AGO's request. 00:00:14.370 -- 00:00:18.275 I would like to turn the call over to Chris Taylor, Vice President of Investor Relations 00:00:18.275 -- 00:00:21.637 and Corporate Communications for AGOs. 00:00:23.402 -- 00:00:27.501 Thank you, Operator. Good morning, everyone, and welcome to AGIOS conference call and 00:00:27.501 -- 00:00:32.549 webcast to discuss our first quarter 2025 financial results and recent 00:00:32.549 -- 00:00:37.936 business highlights. You can access the slides for today's call by going to the investors 00:00:37.936 -- 00:00:41.521 section of our website, agios.com. 00:00:41.521 -- 00:00:46.028 On today's call, we'll hear from our Chief Executive Officer, Brian Goff, Dr. 00:00:46.028 -- 00:00:51.596 Sarah Hewins, Chief Medical Officer and Head of Research and Development, Sveta Milanova, 00:00:51.596 -- 00:00:58.037 Chief Commercial Officer, and Cecilia Jones, Chief Financial Officer. 00:00:58.037 -- 00:01:01.820 Before we get started, I would like to remind everyone that some of the statements we 00:01:01.820 -- 00:01:05.084 make on this call will include forward-looking statements. 00:01:05.084 -- 00:01:10.569 Actual events and results could differ materially from those expressed or implied by 00:01:10.569 -- 00:01:15.174 any forward-looking statements as a result of various risks, uncertainties, and other 00:01:15.174 -- 00:01:20.086 factors, including those set forth in our most recent f...